Danaher (DHR) - Stock Price & Dividends

Danaher Corporation, listed under the ticker symbol DHR on the NYSE, operates worldwide in designing, manufacturing, and marketing an array of professional, medical, industrial, and commercial products and services.

Within its Biotechnology segment, Danaher offers a wide range of bioprocess technologies, consumables, lab filtration/separation/purification solutions, as well as lab-scale protein purification and analytical tools. It also provides healthcare filtration solutions and diverse reagents and membranes.

The Life Sciences segment specializes in mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting/characterization, microscopes, genomics consumables, and gene and cell therapy products. These offerings cater to pharmaceutical, biopharmaceutical, food/beverage, medical, life sciences companies, universities, research institutions, and industrial manufacturers.

The Diagnostics segment focuses on chemistry, immunoassay, microbiology, and automation systems, along with hematology, molecular, acute care, and pathology diagnostics products. Danaher provides clinical instruments, reagents, software, and services to hospitals, physicians' offices, reference laboratories, and various critical care settings.

The Environmental & Applied Solutions division delivers instrumentation, consumables, software, services, and disinfection systems for analyzing, treating, and managing different types of water sources. Additionally, it offers solutions for color/appearance management, packaging design/quality management, printing, marking, coding, and traceability for consumer, pharmaceutical, and industrial products.

Originally known as Diversified Mortgage Investors, Inc., Danaher Corporation was rebranded in 1984. With its establishment dating back to 1969, the company is headquartered in Washington, District of Columbia. More information can be found on their website: https://www.danaher.com.